Company intelligence / Profile preview

Flosonics Medical

Sudbury, Ontario, Canada

Ownership: Private
Employees: ~93
Development stage: Other

Overview

Flosonics Medical’s FloPatch has completed clinical studies in trauma and sepsis care, demonstrating improved precision in fluid management and received FDA 510(k) clearance in 2023. It is now commercially deployed in ICUs, with studies documenting increased protocol compliance and improved outcomes for high-risk patients.[8][6][12][13]

Therapeutic areas: OtherInfectious Diseases
Modalities: DeviceWearable Device
Industry: Physiological Monitoring

Partnerships

Lovell Government Services (U.S. federal health access partner)[4][7]Sutter Health[2][7]Mount Sinai Hospital[8]

Beyond the preview

Go deeper on Flosonics Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flosonics Medical.

Explore the full profile